Screening and prevention of gestational hypertension and preeclampsia
Official title: The Project of Gestational Hypertension and Preeclampsia Screening and Prevention
Run by The Third Affiliated Hospital of Guangzhou Medical University · NCT06383858 · Data updated 2026-11-12
This study is testing a new way to identify and manage pregnant women at high risk for preeclampsia to help prevent complications for both mothers and babies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 50000 (estimated) |
| Sponsor | The Third Affiliated Hospital of Guangzhou Medical University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Status | Recruiting |
| Started | August 1, 2023 |
| Main results expected | December 31, 2028 |
| Study ends | December 31, 2028 |
| Registry record updated | September 19, 2024 |
| Trial ID | NCT06383858 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pregnant women who have been screened for preeclampsia risk based on clinical guidelines.
✕Probably not a fit
Patients with severe fetal malformations or those who have been using aspirin regularly prior to joining the study may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to evaluate a preeclampsia risk screening scheme based on maternal high-risk factors and placental growth factor (PlGF) detection. It focuses on early prediction and targeted management of high-risk pregnant women to reduce the incidence of preeclampsia and associated complications. By establishing appropriate screening and prevention standards for the Chinese population, the study seeks to significantly lower maternal and fetal mortality rates. The methodology involves real-world assessments and interventions to improve outcomes for pregnant women.
Why it matters
Potential benefit: If successful, this study could lead to a significant reduction in maternal and fetal deaths associated with preeclampsia.
How similar studies have gone: Other studies have shown success with similar screening approaches, indicating potential for effective intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 1\) Pregnant women who have been screened for pre-eclampsia risk according to the clinical risk factors listed in NICE guidelines (2019); * 2\) Based on the authoritative guideline of Figo and the consensus of experts in China, pregnant women who routinely use maternal factor +MAP+PLGF±UtA-PI in the first trimester or PLGF or sFlt-1/PLGF in the second and third trimesters to assess the risk of preeclampsia. * 3\) Meet any of the above conditions, join the group voluntarily, and sign the informed consent form. Exclusion Criteria: * 1\) Severe fetal malformation or abnormality (no fetal heartbeat); * 2\) Those who regularly use aspirin before joining the group; * 3\) There are obvious other abnormal signs, laboratory tests or other clinical d• iseases, which are judged by the researcher to be not suitable for participating in researchers; * 4\) Unable to obtain follow-up and delivery information.
Where it's running
-
Fang He
Guangzhou, Guangdong, China Recruiting
Study contacts
- Principal investigator: Dunjin Chen, Professor — The Third Affiliated Hospital of Guangzhou Medical University
- Study coordinator: Dunjin Chen, Professor
- Email: gzdrchen@gzhmu.edu.cn
- Phone: 18928916722
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Adverse Pregnancy Outcomes in Uganda through Partnerships and Innovation
This study tests whether everyday health data, ultrasound, and blood samples from first-time pregnant women in Uganda can help predict problems like preeclampsia, fetal growth restriction, and preterm birth.
-
Internal jugular vein collapsibility to gauge volume status in preeclampsia vs. normal pregnancy
This study tests whether ultrasound of the internal jugular vein can show differences in fluid status between preeclamptic pregnant people and those with normal blood pressure during planned cesarean delivery.
-
Higher vs lower daily aspirin in high-risk pregnant people
This study tests whether taking 150 mg of aspirin daily is more effective than 75 mg daily in preventing preeclampsia among pregnant people at high risk.
-
Community health worker support to lower blood pressure after pregnancy with high blood pressure
Postpartum patients with high blood pressure after pregnancy will try a program where a trained community health worker helps them monitor blood pressure and manage care for 6 months to see if it lowers blood pressure compared with usual care.
-
Role of Progesterone Membrane Receptors in Preeclampsia
This study looks at whether the levels of progesterone membrane receptors in the placenta differ between women with preeclampsia and healthy pregnant women to understand the condition better.
-
Endothelial Biomarkers in Pregnancy: Endothelial Extracellular Vesicles and Hypertensive Disorders
This study tests whether endothelial extracellular vesicles in the blood differ between normotensive pregnant women and those with hypertensive disorders of pregnancy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.